Effects of anti-angiogenesis on glioblastoma growth and migration: model to clinical predictions.
Glioblastoma multiforme (GBM) causes significant neurological morbidity and short survival times. Brain invasion by GBM is associated with poor prognosis. Recent clinical trials of bevacizumab in newly-diagnosed GBM found no beneficial effects on overall survival times; however, the baseline health-...
Main Authors: | Elizabeth Scribner, Olivier Saut, Paula Province, Asim Bag, Thierry Colin, Hassan M Fathallah-Shaykh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4266618?pdf=render |
Similar Items
-
Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.
by: Fabio Raman, et al.
Published: (2016-01-01) -
Single Cell Mathematical Model Successfully Replicates Key Features of GBM: Go-Or-Grow Is Not Necessary.
by: Elizabeth Scribner, et al.
Published: (2017-01-01) -
Dynamics of the Drosophila circadian clock: theoretical anti-jitter network and controlled chaos.
by: Hassan M Fathallah-Shaykh
Published: (2010-01-01) -
Apelin Controls Angiogenesis-Dependent Glioblastoma Growth
by: Anne Frisch, et al.
Published: (2020-06-01) -
Angiogenesis and radiological tumor growth in patients with glioblastoma
by: Vilde Elisabeth Mikkelsen, et al.
Published: (2018-09-01)